Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides - PubMed (original) (raw)
. 2004 Mar-Apr;15(2):290-9.
doi: 10.1021/bc034221g.
Affiliations
- PMID: 15025524
- DOI: 10.1021/bc034221g
Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides
Hong M Moulton et al. Bioconjug Chem. 2004 Mar-Apr.
Abstract
Although the sequence specificity, biostability, and low toxicity of PMO (phosphorodiamidate morpholino oligomers) make them good antisense agents to study gene function, their limited ability to cross cell membranes limits their use in cell culture. In this paper we show that conjugation to arginine-rich peptides significantly enhanced the cellular uptake of PMO. The factors that affect the conjugate's cellular uptake and its antisense activity toward a targeted mRNA were investigated. Factors studied include the number of arginines in the peptide, the choice of cross-linker, the peptide conjugation position, the length of the PMO, and the cell culture conditions. Delivery of PMO to the cell nucleus and cytosol required conjugation rather than complexation of peptides to PMO. R(9)F(2)C was best suited to deliver a PMO to its target RNA resulting in the strongest antisense effect. By simply adding the R(9)F(2)C-PMO conjugate into the cell culture medium at low microM concentration, missplicing of pre-mRNA was corrected. This particular peptide-conjugated PMO was more effective than the PMO conjugated to the transmembrane transport peptides of HIV-1 Tat protein, Drosophila antennapedia protein, or to peptides with fewer arginines. Length of PMO did not affect a peptide's delivery efficacy, but all other factors were important. R(9)F(2)C peptide provided a simple and efficient delivery of PMO to a RNA target. Conjugation of peptide to PMO enhances the opportunities to evaluate gene functions in cell cultures.
Similar articles
- Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
Nelson MH, Stein DA, Kroeker AD, Hatlevig SA, Iversen PL, Moulton HM. Nelson MH, et al. Bioconjug Chem. 2005 Jul-Aug;16(4):959-66. doi: 10.1021/bc0501045. Bioconjug Chem. 2005. PMID: 16029037 - Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
Tünnemann G, Ter-Avetisyan G, Martin RM, Stöckl M, Herrmann A, Cardoso MC. Tünnemann G, et al. J Pept Sci. 2008 Apr;14(4):469-76. doi: 10.1002/psc.968. J Pept Sci. 2008. PMID: 18069724 - Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS, Hatlevig SA, Hassinger JN, Iversen PL, Moulton HM. Youngblood DS, et al. Bioconjug Chem. 2007 Jan-Feb;18(1):50-60. doi: 10.1021/bc060138s. Bioconjug Chem. 2007. PMID: 17226957 - Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
Moulton HM, Fletcher S, Neuman BW, McClorey G, Stein DA, Abes S, Wilton SD, Buchmeier MJ, Lebleu B, Iversen PL. Moulton HM, et al. Biochem Soc Trans. 2007 Aug;35(Pt 4):826-8. doi: 10.1042/BST0350826. Biochem Soc Trans. 2007. PMID: 17635157 Review. - Peptide-assisted delivery of steric-blocking antisense oligomers.
Moulton HM, Moulton JD. Moulton HM, et al. Curr Opin Mol Ther. 2003 Apr;5(2):123-32. Curr Opin Mol Ther. 2003. PMID: 12772501 Review.
Cited by
- Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA.
Sakai A, Singh G, Khoshbakht M, Bittner S, Löhr CV, Diaz-Tapia R, Warang P, White K, Luo LL, Tolbert B, Blanco M, Chow A, Guttman M, Li C, Bao Y, Ho J, Maurer-Stroh S, Chatterjee A, Chanda S, García-Sastre A, Schotsaert M, Teijaro JR, Moulton HM, Stein DA. Sakai A, et al. Mol Ther Nucleic Acids. 2024 Sep 10;35(4):102331. doi: 10.1016/j.omtn.2024.102331. eCollection 2024 Dec 10. Mol Ther Nucleic Acids. 2024. PMID: 39376996 Free PMC article. - Antisense and Functional Nucleic Acids in Rational Drug Development.
Penchovsky R, Georgieva AV, Dyakova V, Traykovska M, Pavlova N. Penchovsky R, et al. Antibiotics (Basel). 2024 Feb 27;13(3):221. doi: 10.3390/antibiotics13030221. Antibiotics (Basel). 2024. PMID: 38534656 Free PMC article. Review. - Emerging Landscape of Supercharged Proteins and Peptides for Drug Delivery.
Wang L, Geng J, Wang H. Wang L, et al. ACS Pharmacol Transl Sci. 2024 Feb 21;7(3):614-629. doi: 10.1021/acsptsci.3c00397. eCollection 2024 Mar 8. ACS Pharmacol Transl Sci. 2024. PMID: 38481692 Review. - Targeting RNA with synthetic oligonucleotides: Clinical success invites new challenges.
Hofman CR, Corey DR. Hofman CR, et al. Cell Chem Biol. 2024 Jan 18;31(1):125-138. doi: 10.1016/j.chembiol.2023.09.005. Epub 2023 Oct 6. Cell Chem Biol. 2024. PMID: 37804835 Review. - Self-transfecting GMO-PMO chimera targeting Nanog enable gene silencing in vitro and suppresses tumor growth in 4T1 allografts in mouse.
Das U, Kundu J, Shaw P, Bose C, Ghosh A, Gupta S, Sarkar S, Bhadra J, Sinha S. Das U, et al. Mol Ther Nucleic Acids. 2023 Mar 21;32:203-228. doi: 10.1016/j.omtn.2023.03.011. eCollection 2023 Jun 13. Mol Ther Nucleic Acids. 2023. PMID: 37078062 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases